Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Inhibits urokinase-type plasminogen activator. Additionally we are shipping SERPINB2 Kits (46) and SERPINB2 Proteins (24) and many more products for this protein.
Showing 10 out of 123 products:
Dog (Canine) Polyclonal SERPINB2 Primary Antibody for WB - ABIN2786668
Stutchbury, Al-Ejeh, Stillfried, Croucher, Andrews, Irving, Links, Ranson: Preclinical evaluation of 213Bi-labeled plasminogen activator inhibitor type 2 in an orthotopic murine xenogenic model of human breast carcinoma. in Molecular cancer therapeutics 2007
Show all 2 references for ABIN2786668
Human Polyclonal SERPINB2 Primary Antibody for IHC (p), WB - ABIN390477
Di Bernardo, Matakidou, Eisen, Houlston,: Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis. in Lung cancer (Amsterdam, Netherlands) 2009
Show all 2 references for ABIN390477
Human Polyclonal SERPINB2 Primary Antibody for EIA, WB - ABIN401464
Macaluso, Montanari, Marshall, Gambone, Tosi, Giordano, Massaro-Giordano: Cytoplasmic and nuclear interaction between Rb family proteins and PAI-2: a physiological crosstalk in human corneal and conjunctival epithelial cells. in Cell death and differentiation 2006
The variant of PAI-2 gene was associated with coronary artery disease and recurrent coronary event risk in Chinese Han population, in Xinjiang.
SerpinB2 plays an important role in proteostas
a total of 500 ESCC cases and 500 matched controls in a Southwest China population were evaluated for six SNPs in the exons of three Serpin genes (SerpinB5 (show SERPINB5 Antibodies), SerpinB2, and SerpinE1 (show SERPINE1 Antibodies)).
PAI-2 was up-regulated in tensioned keloid fibroblasts and normal fibroblasts, but more so in keloid cells. Knockdown of PAI2 reduced cell proliferation in fibroblasts under tension.
Soluble guanylate cyclase activators might alleviate or reverse vascular remodeling in pulmonary hypertension through the up-regulation of PAI-2.
We found no association between allele frequency and risk of multiples sclerosis for any single nucleotide polymorphism investigated for serpinb2
A role for SERPINB2 in patients with head and neck squamous cell carcinoma.
Plasminogen activator inhibitor-2 polymorphism associates with recurrent coronary event risk in patients with high HDL (show HSD11B1 Antibodies) and C-reactive protein (show CRP Antibodies) levels.
PSMB1 is part of the transcriptional machinery required for gastrin stimulated expression of PAI-2 and Reg1.
SerpinB2 can be induced by lentiviral infection in vivo.
Inhibits urokinase-type plasminogen activator. The monocyte derived PAI-2 is distinct from the endothelial cell- derived PAI-1.
plasminogen activator inhibitor 2
, monocyte Arg-serpin
, placental plasminogen activator inhibitor
, plasminogen activator inhibitor, type II (arginine-serpin)
, serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 2
, serpin B2
, urokinase inhibitor